{"id":"keto-amino-acids","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Metallic taste"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Keto-amino acids (the α-ketoacid analogs of essential amino acids) are metabolized to their corresponding amino acids through transamination, allowing protein synthesis without accumulating excess nitrogen. This is particularly useful in chronic kidney disease and hepatic encephalopathy, where nitrogen retention is problematic. The α-ketoacid forms reduce the dietary protein burden while maintaining amino acid availability.","oneSentence":"Keto-amino acids provide nitrogen and carbon skeletons for protein synthesis while reducing the nitrogen load in patients with renal or hepatic impairment.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:51:03.764Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic kidney disease with hyperazotemia (to reduce protein catabolism and nitrogen accumulation)"},{"name":"Hepatic encephalopathy (to reduce ammonia-generating amino acid load)"},{"name":"Protein-energy malnutrition in renal failure"}]},"trialDetails":[{"nctId":"NCT06876038","phase":"PHASE2","title":"Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions","status":"NOT_YET_RECRUITING","sponsor":"University of Massachusetts, Boston","startDate":"2026-09","conditions":"Oral Cancer, Oral Cavity Cancer, Oral Leukoplakia","enrollment":65},{"nctId":"NCT07225621","phase":"PHASE2","title":"Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma","status":"RECRUITING","sponsor":"Alpheus Medical, Inc.","startDate":"2026-01-28","conditions":"Glioblastoma, GBM","enrollment":103},{"nctId":"NCT06417281","phase":"PHASE3","title":"Photodynamic Diagnosis for Malignant Brain Glioma With 5-Aminolevulinic Acid（5-ALA）","status":"COMPLETED","sponsor":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.","startDate":"2024-06-19","conditions":"5-aminolevulinic Acid, Malignant Glioma of Brain","enrollment":86},{"nctId":"NCT07144345","phase":"PHASE3","title":"Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2025-11-19","conditions":"Actinic Keratosis","enrollment":160},{"nctId":"NCT07436546","phase":"NA","title":"Prospective Evaluation of Efficacy of Tumescent Steroid Infiltration in Mandibular Third Molar Surgery: a Split Mouth Randomized Study","status":"COMPLETED","sponsor":"Postgraduate Institute of Dental Sciences Rohtak","startDate":"2025-03-23","conditions":"Impacted Third Molar, Impacted Third Molar Tooth, Third Molar Extraction","enrollment":25},{"nctId":"NCT06665724","phase":"PHASE1","title":"Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)","status":"COMPLETED","sponsor":"Universität Münster","startDate":"2025-01-27","conditions":"Anaplastic Astrocytoma (AA), Anaplastic Oligodendroglioma (AO), Glioblastoma (GBM)","enrollment":16},{"nctId":"NCT07038278","phase":"EARLY_PHASE1","title":"5-AminoLevulinic Acid Aided Resection Margins in Sarcoma","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-04-01","conditions":"Soft Tissue Sarcoma (STS)","enrollment":20},{"nctId":"NCT07076472","phase":"EARLY_PHASE1","title":"Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-08-14","conditions":"Progressive Glioblastoma, Recurrent Glioblastoma","enrollment":8},{"nctId":"NCT07144852","phase":"PHASE3","title":"Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2025-11-29","conditions":"Actinic Keratosis","enrollment":260},{"nctId":"NCT05923060","phase":"PHASE2","title":"Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2024-08-25","conditions":"Actinic Keratoses","enrollment":14},{"nctId":"NCT06307548","phase":"PHASE1, PHASE2","title":"Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer","status":"SUSPENDED","sponsor":"Roswell Park Cancer Institute","startDate":"2024-07-30","conditions":"Locally Advanced Colorectal Carcinoma, Recurrent Colorectal Carcinoma, Stage III Colorectal Cancer","enrollment":21},{"nctId":"NCT07201376","phase":"","title":"Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically","status":"RECRUITING","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2025-11-14","conditions":"Non-Melanoma Skin Cancer (NMSC), Benign Skin Growth","enrollment":125},{"nctId":"NCT06777511","phase":"","title":"Advancing Antimicrobial Photodynamic Therapy to Prevent Infection in Osseointegrated Prosthesis Patients","status":"NOT_YET_RECRUITING","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2026-03-01","conditions":"Amputation, Osseointegration","enrollment":10},{"nctId":"NCT06623201","phase":"PHASE1","title":"Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas","status":"RECRUITING","sponsor":"Nathalie Zeitouni","startDate":"2024-10-07","conditions":"Basal Cell Carcinoma (BCC)","enrollment":20},{"nctId":"NCT07359625","phase":"NA","title":"Effects of Ketone Bodies on Insulin Sensitivity","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2025-12-02","conditions":"Insulin Resistance, Obesity & Overweight, Energy Metabolism","enrollment":10},{"nctId":"NCT06907485","phase":"PHASE2","title":"A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients","status":"NOT_YET_RECRUITING","sponsor":"Costas Hadjipanayis","startDate":"2026-08","conditions":"Pediatric Brain Tumor","enrollment":20},{"nctId":"NCT03620773","phase":"PHASE1, PHASE2","title":"Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2018-10-01","conditions":"Type 2 Diabetes Mellitus, Obesity, Bariatric Surgery Candidate","enrollment":24},{"nctId":"NCT07053852","phase":"PHASE1","title":"Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage","status":"COMPLETED","sponsor":"Sherrif Ibrahim","startDate":"2025-06-27","conditions":"Actinic Keratoses, Photodamage","enrollment":10},{"nctId":"NCT04738162","phase":"PHASE2","title":"Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors","status":"COMPLETED","sponsor":"Universität Münster","startDate":"2020-09-25","conditions":"Brain Tumor, Pediatric","enrollment":78},{"nctId":"NCT01426529","phase":"PHASE1","title":"Caveolin-1 and Vascular Dysfunction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2010-10-01","conditions":"Hypertension, Insulin Resistance","enrollment":120},{"nctId":"NCT05020912","phase":"PHASE2","title":"Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2021-12-13","conditions":"Basal Cell Carcinoma","enrollment":28},{"nctId":"NCT06027619","phase":"PHASE2","title":"Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2023-10-02","conditions":"Actinic Keratosis","enrollment":30},{"nctId":"NCT05804370","phase":"PHASE3","title":"Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)","status":"RECRUITING","sponsor":"NX Development Corp","startDate":"2024-05-30","conditions":"Ovarian Cancer","enrollment":170},{"nctId":"NCT02191488","phase":"PHASE1","title":"ALA-induced PpIX Fluorescence During Brain Tumor Resection","status":"ACTIVE_NOT_RECRUITING","sponsor":"David W. Roberts","startDate":"2014-07","conditions":"Brain Tumors","enrollment":540},{"nctId":"NCT05736406","phase":"PHASE1, PHASE2","title":"A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma","status":"RECRUITING","sponsor":"Hemerion Therapeutics","startDate":"2024-02-20","conditions":"Primary Glioblastoma","enrollment":12},{"nctId":"NCT04815083","phase":"PHASE3","title":"Fluorescence Imaging of Carcinoma During Breast Conserving Surgery","status":"TERMINATED","sponsor":"SBI ALApharma Canada, Inc.","startDate":"2021-04-27","conditions":"Breast Neoplasm Female, Breast Cancer","enrollment":57},{"nctId":"NCT06796660","phase":"EARLY_PHASE1","title":"Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients","status":"NOT_YET_RECRUITING","sponsor":"Liu Zhanghong","startDate":"2025-09-01","conditions":"Renal Insufficiency, Chronic","enrollment":70},{"nctId":"NCT02691923","phase":"PHASE2","title":"Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker","status":"RECRUITING","sponsor":"David W. Roberts","startDate":"2016-03","conditions":"Brain Cancer","enrollment":30},{"nctId":"NCT05101798","phase":"PHASE2","title":"The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2021-09-14","conditions":"Neoplasm, Skull Base Neoplasm","enrollment":7},{"nctId":"NCT05507892","phase":"PHASE2","title":"Renal Mechanism of SGLT2 Inhibition","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2022-10-10","conditions":"Type 2 Diabetes, Diabetic Kidney Disease","enrollment":40},{"nctId":"NCT04965987","phase":"PHASE1","title":"Oxaloacetate in Myasthenia Gravis","status":"WITHDRAWN","sponsor":"University of Kansas Medical Center","startDate":"2025-08","conditions":"Myasthenia Gravis","enrollment":""},{"nctId":"NCT07027670","phase":"PHASE2","title":"Treatment With 5-AminoLEvuliNic Acid Before Cardiac Surgery","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2021-02-01","conditions":"Cardiac Surgical Procedures, Coronary Artery Bypass, Aortic Valve Disease","enrollment":48},{"nctId":"NCT05362409","phase":"PHASE1","title":"Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma","status":"COMPLETED","sponsor":"Alpheus Medical, Inc.","startDate":"2022-06-29","conditions":"High Grade Glioma","enrollment":22},{"nctId":"NCT05065372","phase":"PHASE1","title":"MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes","status":"RECRUITING","sponsor":"Kalie Tommerdahl","startDate":"2022-07-01","conditions":"Type 1 Diabetes, Diabetic Kidney Disease, Cardiovascular Diseases","enrollment":60},{"nctId":"NCT03897491","phase":"PHASE2","title":"PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"photonamic GmbH & Co. KG","startDate":"2021-09-03","conditions":"Glioblastoma","enrollment":20},{"nctId":"NCT06160492","phase":"PHASE3","title":"Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4)","status":"RECRUITING","sponsor":"Lee's Pharmaceutical Limited","startDate":"2025-04-14","conditions":"5-aminolevulinic Acid, Fluorescence-guided Resection","enrollment":144},{"nctId":"NCT02728388","phase":"PHASE2","title":"Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II","status":"RECRUITING","sponsor":"Donald Basel","startDate":"2016-08","conditions":"NEUROFIBROMATOSIS 1","enrollment":30},{"nctId":"NCT06948552","phase":"PHASE2","title":"Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA","status":"NOT_YET_RECRUITING","sponsor":"Henry Ford Health System","startDate":"2025-05","conditions":"Upper Tract Urothelial Carcinoma","enrollment":10},{"nctId":"NCT05008276","phase":"","title":"Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)","status":"RECRUITING","sponsor":"Petter Bjornstad","startDate":"2021-09-27","conditions":"Type 2 Diabetes Mellitus, Diabetic Kidney Disease, Adolescent Obesity","enrollment":100},{"nctId":"NCT04469699","phase":"PHASE2","title":"Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma","status":"TERMINATED","sponsor":"University Hospital Muenster","startDate":"2021-04-12","conditions":"Glioblastoma Multiforme, Adult","enrollment":30},{"nctId":"NCT01689935","phase":"PHASE1","title":"Reduced Side-Effects of Photodynamic Therapy for the Treatment of Moderate to Severe Acne (i-PDT)","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2009-11-01","conditions":"Acne Vulgaris","enrollment":35},{"nctId":"NCT06159842","phase":"PHASE2","title":"Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)","status":"COMPLETED","sponsor":"The Center for Clinical and Cosmetic Research","startDate":"2023-08-08","conditions":"Facial Cutaneous Squamous Cell Carcinoma in Situ","enrollment":32},{"nctId":"NCT03066843","phase":"NA","title":"Photodynamic Therapy Incubation Times for Actinic Keratosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northwestern University","startDate":"2017-03-01","conditions":"Actinic Keratoses","enrollment":60},{"nctId":"NCT06745999","phase":"PHASE4","title":"Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face","status":"RECRUITING","sponsor":"Psoriasis Treatment Center of Central New Jersey","startDate":"2023-05-03","conditions":"Actinic Keratoses","enrollment":40},{"nctId":"NCT05590689","phase":"PHASE1, PHASE2","title":"Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor","status":"RECRUITING","sponsor":"Universität Münster","startDate":"2022-11-09","conditions":"Glioblastoma","enrollment":34},{"nctId":"NCT05709600","phase":"NA","title":"Dietary Interventions During Living Kidney Donations","status":"RECRUITING","sponsor":"University of Cologne","startDate":"2023-02-01","conditions":"Living-Kidney Donors","enrollment":80},{"nctId":"NCT04845919","phase":"PHASE2","title":"Sonodynamic Therapy with ExAblate System in Glioblastoma Patients","status":"COMPLETED","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2023-02-22","conditions":"Glioblastoma Multiforme","enrollment":5},{"nctId":"NCT06452563","phase":"PHASE4","title":"Amino Acids Supplementation and Exercise Intervention in Hemodialysis Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mansoura University","startDate":"2024-05-12","conditions":"Hemodialysis Complication, Malnutrition","enrollment":100},{"nctId":"NCT06577311","phase":"PHASE2","title":"Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)","status":"RECRUITING","sponsor":"The Center for Clinical and Cosmetic Research","startDate":"2024-08-14","conditions":"Cutaneous Squamous Cell Carcinoma","enrollment":20},{"nctId":"NCT05952544","phase":"","title":"Effect of Protein Restriction Plus EAA/KA Supplementation on GFR Decline in CKD","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2023-07-20","conditions":"Chronic Kidney Diseases","enrollment":400},{"nctId":"NCT06252727","phase":"PHASE1","title":"Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES)","status":"WITHDRAWN","sponsor":"University of California, Davis","startDate":"2024-07","conditions":"Soft Tissue Sarcoma, Soft Tissue Sarcoma Adult","enrollment":""},{"nctId":"NCT03963102","phase":"PHASE4","title":"Duration of Ameluz Application in Acral Actinic Keratoses Response","status":"TERMINATED","sponsor":"Royal Cornwall Hospitals Trust","startDate":"2019-10-30","conditions":"Actinic Keratoses, Photodamaged Skin","enrollment":28},{"nctId":"NCT03327831","phase":"PHASE4","title":"Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2015-04","conditions":"Actinic Keratosis","enrollment":30},{"nctId":"NCT05279118","phase":"PHASE2, PHASE3","title":"Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"All India Institute of Medical Sciences","startDate":"2022-04-18","conditions":"Ketogenic Diet, West Syndrome, Infantile Spasm","enrollment":80},{"nctId":"NCT04305470","phase":"PHASE3","title":"Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma","status":"COMPLETED","sponsor":"NX Development Corp","startDate":"2020-10-28","conditions":"Meningioma","enrollment":108},{"nctId":"NCT06387186","phase":"PHASE1","title":"Leucine Enriched Essential Amino Acid Powder as an Add-on to a Classic Ketogenic Diet in Refractory Epilepsy","status":"NOT_YET_RECRUITING","sponsor":"Elizabeth Anne Thiele","startDate":"2024-04","conditions":"Refractory Epilepsy, Drug Resistant Epilepsy","enrollment":15},{"nctId":"NCT05319990","phase":"","title":"Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2022-03-09","conditions":"Type 1 Diabetes, Diabetic Kidney Disease, Diabetes Complications","enrollment":100},{"nctId":"NCT04164849","phase":"PHASE1, PHASE2","title":"Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid","status":"COMPLETED","sponsor":"University Hospital, Akershus","startDate":"2019-11-22","conditions":"Crohn Disease","enrollment":7},{"nctId":"NCT01128218","phase":"PHASE1, PHASE2","title":"A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors","status":"COMPLETED","sponsor":"Southern Illinois University","startDate":"2011-03","conditions":"Brain Neoplasms","enrollment":33},{"nctId":"NCT01502280","phase":"PHASE3","title":"Fluorescence-guided Surgery for Low- and High-grade Gliomas","status":"COMPLETED","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2010-11","conditions":"Glioma","enrollment":127},{"nctId":"NCT03584217","phase":"PHASE1, PHASE2","title":"Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study","status":"UNKNOWN","sponsor":"University of Colorado, Denver","startDate":"2018-10-01","conditions":"Type 2 Diabetes Mellitus, Obesity, Nephropathy","enrollment":100},{"nctId":"NCT01966120","phase":"PHASE3","title":"Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2013-10","conditions":"Actinic Keratosis","enrollment":87},{"nctId":"NCT05850377","phase":"","title":"5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas","status":"NOT_YET_RECRUITING","sponsor":"Sociedad de Lucha Contra el Cáncer del Ecuador","startDate":"2023-06-01","conditions":"High Grade Glioma, Glioma, Glioma, Malignant","enrollment":90},{"nctId":"NCT04074668","phase":"","title":"Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2020-01-01","conditions":"Diabetic Kidney Disease, Type 1 Diabetes, Diabetes","enrollment":58},{"nctId":"NCT03109353","phase":"PHASE1, PHASE2","title":"Modification of Extracorporeal Photopheresis in Cutaneous T-cell Lymphoma or Chronic Graft-versus-host Disease","status":"COMPLETED","sponsor":"St. Olavs Hospital","startDate":"2017-09-20","conditions":"Cutaneous T-Cell Lymphoma, Unspecified, Chronic Graft Versus Host Disease in Skin","enrollment":7},{"nctId":"NCT03281811","phase":"EARLY_PHASE1","title":"Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2017-11-13","conditions":"Refractory Mycosis Fungoides","enrollment":11},{"nctId":"NCT02075671","phase":"PHASE4","title":"Photodynamic Therapy for Papulopustular Rosacea","status":"COMPLETED","sponsor":"George Washington University","startDate":"2014-04-24","conditions":"Rosacea, Papulopustular Rosacea","enrollment":30},{"nctId":"NCT01511042","phase":"","title":"Vascular Dysfunction in Diabetes: Genes and Hormones","status":"TERMINATED","sponsor":"Brigham and Women's Hospital","startDate":"1999-12","conditions":"Diabetes Mellitus","enrollment":100},{"nctId":"NCT02144077","phase":"PHASE3","title":"Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2014-01-28","conditions":"Basal Cell Carcinoma (BCC)","enrollment":281},{"nctId":"NCT05530356","phase":"","title":"Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study","status":"ENROLLING_BY_INVITATION","sponsor":"University of Colorado, Denver","startDate":"2022-09-30","conditions":"Type 2 Diabetes, Diabetes Type 2, Diabetic Nephropathies","enrollment":100},{"nctId":"NCT02516501","phase":"NA","title":"Impact of a Ketogenic Diet Intervention During Radiotherapy on Body Composition","status":"COMPLETED","sponsor":"MVZ Leopoldina GmbH","startDate":"2015-06","conditions":"Neoplasms","enrollment":156},{"nctId":"NCT04055688","phase":"","title":"Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2019-08-15","conditions":"Brain Tumor, Glioma","enrollment":20},{"nctId":"NCT04019431","phase":"NA","title":"Effect of a Very Low-Calorie Ketogenic Diet on Gut Microbiota and Fat Distribution","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2019-07-01","conditions":"Obesity","enrollment":50},{"nctId":"NCT02155452","phase":"","title":"Fluorescence and Glioma Heterogeneity","status":"COMPLETED","sponsor":"Tata Memorial Hospital","startDate":"2014-05","conditions":"Malignant Gliomas","enrollment":25},{"nctId":"NCT03618420","phase":"PHASE1, PHASE2","title":"Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2018-10-01","conditions":"Diabetes Mellitus, Type 1, Nephropathy, Diabetic Nephropathies","enrollment":50},{"nctId":"NCT05287659","phase":"NA","title":"Low Calorie Diet or VLCKD Combined With Physical Training for Preserving Muscle Mass During Weight Loss in Sarcopenic Obesity","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2022-01-03","conditions":"Sarcopenic Obesity","enrollment":50},{"nctId":"NCT03322293","phase":"PHASE1","title":"Daylight Photodynamic Therapy for Actinic Keratosis","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2017-12-01","conditions":"Actinic Keratoses","enrollment":24},{"nctId":"NCT05228483","phase":"NA","title":"Carbon Dioxide（CO2）Fractional Laser Plus Photodynamic Therapy in Female Patients With Vulvar Lichen Sclerosus","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2021-11-23","conditions":"Vulva Lichen Sclerosus","enrollment":134},{"nctId":"NCT03022903","phase":"NA","title":"Blue Light Photodynamic Therapy Treatment for Distal and Lateral Subungual Toenail Onychomycosis","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2015-09","conditions":"Toenail Onychomycosis, Distal and Lateral Subungual Toenail Onychomycosis","enrollment":2},{"nctId":"NCT02751151","phase":"NA","title":"Photodynamic Therapy for Prevention of Nonmelanoma Skin Cancer in Organ Transplant Recipients","status":"COMPLETED","sponsor":"Inova Health Care Services","startDate":"2016-02","conditions":"Nonmelanoma Skin Cancers","enrollment":10},{"nctId":"NCT00752323","phase":"PHASE2","title":"Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma","status":"COMPLETED","sponsor":"Andrew Sloan, MD","startDate":"2009-12-08","conditions":"Brain and Central Nervous System Tumors","enrollment":73},{"nctId":"NCT03114111","phase":"EARLY_PHASE1","title":"Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2017-01","conditions":"Seborrheic Dermatitis","enrollment":12},{"nctId":"NCT01682811","phase":"PHASE1","title":"Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)","status":"COMPLETED","sponsor":"Harry T Whelan, MD","startDate":"2012-03-12","conditions":"Neurofibromatoses","enrollment":20},{"nctId":"NCT01456208","phase":"","title":"Genetic Mechanisms in Human Hypertension","status":"TERMINATED","sponsor":"Brigham and Women's Hospital","startDate":"1999-10","conditions":"Hypertension","enrollment":150},{"nctId":"NCT04390802","phase":"","title":"A Pilot Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Pituitary Adenomas","status":"UNKNOWN","sponsor":"Massachusetts General Hospital","startDate":"2021-07","conditions":"Pituitary Adenoma","enrollment":40},{"nctId":"NCT03638622","phase":"PHASE1, PHASE2","title":"Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral Cancer Cancer.","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-03-10","conditions":"Oral Cancer","enrollment":30},{"nctId":"NCT02867722","phase":"NA","title":"Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States","status":"WITHDRAWN","sponsor":"Brigham and Women's Hospital","startDate":"2020-12","conditions":"Actinic Keratosis, Non-melanoma Skin Cancer","enrollment":""},{"nctId":"NCT04709289","phase":"NA","title":"Adverse Effects of ALA-PDT for the Treatment of Moderate to Severe Acne Vulgaris: a Prospective Study","status":"COMPLETED","sponsor":"Shanghai Dermatology Hospital","startDate":"2020-01-01","conditions":"Acne Vulgaris","enrollment":40},{"nctId":"NCT04636242","phase":"PHASE3","title":"Photodynamic Therapy for Cutibacterium Acnes (C. Acnes) Decolonization of the Shoulder Dermis","status":"UNKNOWN","sponsor":"Rothman Institute Orthopaedics","startDate":"2019-08-22","conditions":"C. Acnes, Phototherapy, Postoperative Infection","enrollment":120},{"nctId":"NCT04631250","phase":"NA","title":"Conventional Photodynamic Therapy Versus Daylight Photodynamic Therapy for The Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2018-11-01","conditions":"Acne Vulgaris","enrollment":15},{"nctId":"NCT01556009","phase":"PHASE2","title":"Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas","status":"COMPLETED","sponsor":"UCSF Benioff Children's Hospital Oakland","startDate":"2012-04","conditions":"Basal Cell Nevus Syndrome, Gorlin's Syndrome","enrollment":24},{"nctId":"NCT04492228","phase":"NA","title":"Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome","status":"UNKNOWN","sponsor":"Ospedale Policlinico San Martino","startDate":"2020-09-01","conditions":"Covid19, Ketogenic Dieting","enrollment":100},{"nctId":"NCT04542629","phase":"PHASE4","title":"Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2020-10-01","conditions":"Refractory Epilepsy","enrollment":140},{"nctId":"NCT02157623","phase":"NA","title":"Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome","status":"COMPLETED","sponsor":"Edward Maytin, MD, PhD","startDate":"2016-02-01","conditions":"Basal Cell Nevus Syndrome","enrollment":3},{"nctId":"NCT04020653","phase":"PHASE2","title":"A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria","status":"WITHDRAWN","sponsor":"Neopharma Japan Co., Ltd.","startDate":"2019-09-06","conditions":"Malaria","enrollment":""},{"nctId":"NCT00977795","phase":"PHASE1, PHASE2","title":"A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors","status":"WITHDRAWN","sponsor":"Endeavor Health","startDate":"2009-09","conditions":"Brain Neoplasms","enrollment":""},{"nctId":"NCT02464709","phase":"PHASE4","title":"Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)","status":"COMPLETED","sponsor":"Joint Authority for Päijät-Häme Social and Health Care","startDate":"2015-06","conditions":"Actinic Keratosis, Natural Daylight Photodynamic Therapy","enrollment":72},{"nctId":"NCT00870779","phase":"PHASE1","title":"Fluorescence Guided Resection of Brain Tumors","status":"COMPLETED","sponsor":"David W. Roberts","startDate":"2007-05","conditions":"Brain Tumors","enrollment":105},{"nctId":"NCT00978081","phase":"PHASE1","title":"Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors","status":"COMPLETED","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2009-01","conditions":"Head and Neck Cancer, Precancerous Condition","enrollment":35},{"nctId":"NCT02886975","phase":"NA","title":"Effects of Low Protein Diet in Preventing the Progression of Chronic Kidney Disease(CKD)---a Prospective Study","status":"UNKNOWN","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2016-08","conditions":"Renal Insufficiency, Chronic","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":23,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ketosteril®(Fresenius Kabi)"],"phase":"marketed","status":"active","brandName":"keto-amino acids","genericName":"keto-amino acids","companyName":"YUAN Wei-jie","companyId":"yuan-wei-jie","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Keto-amino acids provide nitrogen and carbon skeletons for protein synthesis while reducing the nitrogen load in patients with renal or hepatic impairment. Used for Chronic kidney disease with hyperazotemia (to reduce protein catabolism and nitrogen accumulation), Hepatic encephalopathy (to reduce ammonia-generating amino acid load), Protein-energy malnutrition in renal failure.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}